NVO - Novo Nordisk A/S

NYSE - Nasdaq Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
Currency in DKK. All numbers in thousands
Revenue31/12/201831/12/201731/12/201631/12/2015
Total revenue111,831,000111,696,000111,780,000107,927,000
Cost of revenue17,617,00017,632,00017,183,00016,188,000
Gross profit94,214,00094,064,00094,597,00091,739,000
Operating expenses
Research development14,805,00014,014,00014,563,00013,608,000
Selling general and administrative33,313,00032,124,00032,339,00032,169,000
Non-recurring----
Others-1,444,000-1,333,000-1,105,000-657,000
Total operating expenses64,705,00062,729,00063,348,00061,308,000
Operating income or loss47,126,00048,967,00048,432,00046,619,000
Income from continuing operations
Total other income/expenses net489,000-287,000-634,000-3,136,000
Earnings before interest and taxes47,126,00048,967,00048,432,00046,619,000
Interest expense-85,000-90,000-65,000-67,000
Income before tax47,615,00048,680,00047,798,00043,483,000
Income tax expense8,987,00010,550,0009,873,0008,623,000
Minority interest----
Net income from continuing ops38,628,00038,130,00037,925,00034,860,000
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income38,628,00038,130,00037,925,00034,860,000
Preferred stock and other adjustments----
Net income applicable to common shares38,628,00038,130,00037,925,00034,860,000
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more